Showing results (71-80 of 153) with videos related to
Sort By:
Pageof 16
Journal of Thrombosis and Haemostasis : JTH|October 12, 2013
Presence of varicose veins in cancer patients increases the risk for occurrence of venous thromboembolismO Königsbrügge, F Lötsch, E-M Reitter, et al.Digestive Diseases and Sciences|January 1, 1991
Cellular immunodeficiency in protein-losing enteropathy. Predominant reduction of CD3+ and CD4+ lymphocytesC Müller, H Wolf, J Göttlicher, et al.Leukemia & Lymphoma|July 16, 2005
Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumabM A Zeitlinger, M Schmidinger, C C Zielinski, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancerT Brodowicz, T Ciuleanu, J Crawford, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 1, 1995
In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activityC Wiltschke, M Krainer, M Nanut, et al.Cancer|November 1, 1990
Impaired production of tumor necrosis factor in breast cancerC C Zielinski, C Mueller, E Tyl, et al.Cellular Immunology|August 1, 1984
Regulation of NK cell activity by prostaglandin E2: the role of T cellsC C Zielinski, C Gisinger, C Binder, et al.British Journal of Cancer|September 22, 1998
Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancerM Hejna, G V Kornek, M Raderer, et al.Cellular Immunology|March 1, 1984
Dialyzable leukocyte extract (transfer factor) in the treatment of superinfected fistulating tuberculosis of the boneC C Zielinski, E Savoini, M Ciotti, et al.Cancer|October 15, 1986
Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapyC C Zielinski, I Stuller, F Dorner, et al.Pageof 16